Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

Clinical trial NCT06662227 · SUSPENDED

Trial details

NCT number: NCT06662227
Sponsor: Wondercel Biotech (ShenZhen)
Status: SUSPENDED
Phase: Early Phase 1
Study type: INTERVENTIONAL

B Cell Lymphoma B Cell Leukemia B Cell Malignancy

Start date: 2024-10-24
Primary completion: 2027-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.